Pediatric Asthma Controller Trial (PACT)

首次发布于 2006 年 1 月 6 日

12-week Open-label Evaluation of Efficacy and Safety of Indacaterol

计划入组 90 人 · 首次发布于 2010 年 11 月 2 日

Modification Of Disease Outcome In COPD

计划入组 200 人 · 首次发布于 2005 年 9 月 12 日

long-acting VPAC2 agonists (Transition Therapeutics)

Bambuterol

C₁₈H₂₉N₃O₅ · Rx

Amylin agonist long acting (Eli Lilly)

Long Island University

Costa Rica

NAM LONG PTY LTD

Australia

LONG GROVE PHARMACEUTICALS LLC

United States

GSK's Relvar Ellipta Demonstrates Superior Asthma Control in Landmark Real-World Study

European Patent Office Upholds Umeclidinium-Vilanterol Combination Patent Despite Opposition Challenges

AstraZeneca's Breztri Shows Significant Improvement in Phase III Asthma Trials